DEPO Financial Facts

Interest and other income: 67K
Research and development expense: 7.12M
See Full Income Statement

Other assets: 1.37M
Common stock, no par value: 277.91M
See Full Balance Sheet

DepoMed Inc. (DEPO) Earnings

  |   Expand Research on DEPO
Next EPS Date 11/9/16 *Est. EPS Growth Rate 0.0% *Last Qtr.
Average EPS % Beat Rate +1.9% Revenue Growth Rate +23.8% *Last Qtr.
Average % Move 1-Wk after EPS +0.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/3/16 Q216 $0.27$0.25 +$0.02$116.7M$118.2M N/A Details
5/5/16 Q116 $0.12$0.17 -$0.05$104.8M$107.1M N/A Details
2/22/16 Q415 $0.16$0.29 -$0.13$111.2M$110.24M N/A Details
11/9/15 Q315 $0.33$0.19 +$0.14$105M$101.64M Details
7/29/15 Q215 $0.27$0.00 +$0.27$94.3M$88.33M Details
5/11/15 Q115 -$0.13$0.01 -$0.14$31.7M$33.8M Details
2/23/15 Q414 $0.21$0.07 +$0.14$33.9M$18.8M Details
11/5/14 Q314 $0.03-$0.04 +$0.07$51.5M$41.5M Details